뉴스
12 FEB 2014 | ALTEOGEN starts collaboration in mAb biosimilar with KISSEI Pharma.
Under the agreement, ALTEOGEN and KISSEI start collaboration in developing a mAb biosimilar and KISSEI underwrites the allocation of new shares to a third party from ALTEOGEN. Through this business collaboration, ALTEOGEN and KISSEI will continue to further strengthen its efforts to biopharmaceutical business.